Grace Therapeutics, Inc. (GRCE) SEC filings
GRCE SEC filings moved a median of -0.97% by the close. GRCE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GRCE overview →
33 measured GRCE SEC filing events.
Where these GRCE SEC filings landedvs 29 measured GRCE SEC filing reactions
| Middle 50% of GRCE SEC filing reactions | -2.75% to +0.65% |
|---|---|
| Median reaction (to close) | -0.97% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 GRCE SEC filing events with a measured close landed between -2.75% and +0.65%; 34% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Grace Therapeutics, Inc. For: Sep 17 | SEC filing · Form 8-K | +1.42% | -0.94% | |
| Form EFFECT Grace Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | +0.48% | |
| Form S-3 Grace Therapeutics, Inc. | SEC filing · Form S-3 | +1.15% | +0.92% | |
| Form 10-Q Grace Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.43% | -1.43% | |
| Form 8-K Grace Therapeutics, Inc. For: Aug 13 | SEC filing · Form 8-K | +1.43% | -1.43% | |
| Form D Grace Therapeutics, Inc. | SEC filing · Form D | +0.00% | +0.95% | |
| Form 8-K Grace Therapeutics, Inc. For: Aug 04 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Grace Therapeutics, Inc. For: Jul 28 | SEC filing · Form 8-K | -5.04% | -5.46% | |
| Form DEF 14A Grace Therapeutics, Inc. For: Sep 17 | SEC filing · Form DEF | +1.82% | -5.46% | |
| Form DEFA14A Grace Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.82% | -5.46% | |
| Form 10-K Grace Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-K | +2.25% | +7.21% | |
| Form 8-K Grace Therapeutics, Inc. For: Jun 18 | SEC filing · Form 8-K | +2.25% | +7.21% | |
| Form 8-K Grace Therapeutics, Inc. For: Jun 01 | SEC filing · Form 8-K | -0.83% | +0.00% | |
| Form 8-K Grace Therapeutics, Inc. For: Apr 27 | SEC filing · Form 8-K | -3.00% | -7.30% | |
| Form 8-K Grace Therapeutics, Inc. For: Apr 23 | SEC filing · Form 8-K | -2.06% | +7.55% | |
| Form 10-Q Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | -1.10% | -3.29% | |
| Form 8-K Grace Therapeutics, Inc. For: Feb 12 | SEC filing · Form 8-K | -1.10% | -3.29% | |
| Form 8-K Grace Therapeutics, Inc. For: Jan 10 | SEC filing · Form 8-K | +2.47% | -2.75% | |
| Form 10-Q/A Grace Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.14% | +4.98% | |
| Form 10-Q Grace Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.98% | — | |
| Form 8-K Grace Therapeutics, Inc. For: Nov 13 | SEC filing · Form 8-K | +1.98% | — | |
| Form 8-K Grace Therapeutics, Inc. For: Oct 23 | SEC filing · Form 8-K | -0.95% | -0.32% | |
| Form 8-K Grace Therapeutics, Inc. For: Sep 18 | SEC filing · Form 8-K | +0.65% | +0.65% | |
| Form 8-K Grace Therapeutics, Inc. For: Sep 12 | SEC filing · Form 8-K | +1.14% | -0.97% | |
| Form 8-K Grace Therapeutics, Inc. For: Aug 27 | SEC filing · Form 8-K | -1.46% | -5.54% | |
| Form 10-Q Grace Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 8-K Grace Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | +0.00% | — | |
| Form DEF 14A Grace Therapeutics, Inc. For: Sep 12 | SEC filing · Form DEF | +1.79% | -1.62% | |
| Form DEFA14A Grace Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.79% | -1.62% | |
| Form 8-K Grace Therapeutics, Inc. For: Jun 25 | SEC filing · Form 8-K | +5.08% | +0.34% | |
| Form 10-K Grace Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-K | -0.33% | -2.33% | |
| Form 8-K Grace Therapeutics, Inc. For: Jun 23 | SEC filing · Form 8-K | -0.33% | -2.33% | |
| Form 8-K Grace Therapeutics, Inc. For: Apr 09 | SEC filing · Form 8-K | +0.00% | +5.70% |
Keep exploring
More GRCE: earnings → · analyst actions → · GRCE overview →